| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| DOSTARLIMAB | 2022215-59-2 | P0GVQ9A4S5 | P0GVQ9A4S5 | DOSTARLIMAB DOSTARLIMAB [INN] DOSTARLIMAB [USAN] DOSTARLIMAB [WHO-DD] DOSTARLIMAB GXLY [WHO-DD] DOSTARLIMAB-GXLY GSK4057190 GSK-4057190 IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1 (PDCD1)) (HUMANIZED CLONE ABT1 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONE ABT1 .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN PROGRAMMED CELL DEATH PROPTEIN 1 (PROTEIN PD-1, CD279 ANTIGEN))HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-440) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*01 (92%) (IGHD)-IGHJ6*01 (93%)) (8.8.6) (1-113) -HOMO SAPIENS IGHG4*01 (CH1 C27>G(140), H87>K(200), K88>H(201), H S10>P(221)) (114-440)) (127-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (92%) IGKJ4*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (107'-214')), DIMER (219-219'':222-222'')-BISDISULFIDE JEMPERLI TSR042 TSR-042 WBP285 WBP-285 |